ACADIA PHARMACEUTICALS INC (ACAD) › Capital ExpendituresACADIA PHARMACEUTICALS INC (ACAD) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $3.0K2013: $618.0K2014: $180.0K2015: $2.14M2016: $1.51M2017: $812.0K2018: $2.10M2019: $1.13M2020: $7.59M2021: $1.12M2022: $02023: $50.0K2024: $523.0K2025: $4.69M$4.69M2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$4.69M+796.7%2024$523.0K+946.0%2023$50.0K—2022$0-100.0%2021$1.12M-85.2%2020$7.59M+572.0%2019$1.13M-46.3%2018$2.10M+159.1%2017$812.0K-46.1%2016$1.51M-29.7%2015$2.14M+1089.4%2014$180.0K-70.9%2013$618.0K—2011$3.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share